HemaSphere (Jun 2022)

P1234: REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION

  • S.-J. Wu,
  • C.-K. Liao,
  • Y.-W. Wang,
  • M.-C. Wang

DOI
https://doi.org/10.1097/01.HS9.0000847800.04742.1b
Journal volume & issue
Vol. 6
pp. 1119 – 1120

Abstract

Read online

No abstracts available.